Want to see MRM full AI Analyst Report?
Total Valuation
MEDIROM Healthcare Technologies has a market cap or net worth of $7.88M. The enterprise value is $3.27B.
Market Cap$7.88M
Enterprise Value$3.27B
Share Statistics
MEDIROM Healthcare Technologies has 7,901,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,901,950
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MEDIROM Healthcare Technologies’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is -0.31%.
Return on Equity (ROE)0.16
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)-0.31%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee24.85M
Profits Per Employee413.75K
Employee Count334
Asset Turnover1.03
Inventory Turnover39.92
Valuation Ratios
The current PE Ratio of MEDIROM Healthcare Technologies is ―. MEDIROM Healthcare Technologies’s PEG ratio is 0.24.
PE Ratio―
PS Ratio0.10
PB Ratio0.89
Price to Fair Value0.89
Price to FCF-0.44
Price to Operating Cash Flow―
PEG Ratio0.24
Income Statement
In the last 12 months, MEDIROM Healthcare Technologies had revenue of 8.30B and earned 148.76M in profits. Earnings per share was 29.13.
Revenue8.30B
Gross Profit2.25B
Operating Income-18.10M
Pretax Income47.71M
Net Income148.76M
EBITDA387.50M
Earnings Per Share (EPS)29.13
Cash Flow
In the last 12 months, operating cash flow was -807.42M and capital expenditures -98.29M, giving a free cash flow of -905.71M billion.
Operating Cash Flow-807.42M
Free Cash Flow-905.71M
Free Cash Flow per Share-114.62
Dividends & Yields
MEDIROM Healthcare Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.12
52-Week Price Change-29.58%
50-Day Moving Average1.13
200-Day Moving Average1.61
Relative Strength Index (RSI)36.06
Average Volume (3m)4.82M
Important Dates
MEDIROM Healthcare Technologies upcoming earnings date is Nov 9, 2026, After Close (Confirmed).
Last Earnings DateMay 18, 2026
Next Earnings DateNov 9, 2026
Ex-Dividend Date―
Financial Position
MEDIROM Healthcare Technologies as a current ratio of 0.65, with Debt / Equity ratio of ―
Current Ratio0.65
Quick Ratio0.61
Debt to Market Cap2.27
Net Debt to EBITDA9.36
Interest Coverage Ratio-0.36
Taxes
In the past 12 months, MEDIROM Healthcare Technologies has paid -90.48M in taxes.
Income Tax-90.48M
Effective Tax Rate-1.90
Enterprise Valuation
MEDIROM Healthcare Technologies EV to EBITDA ratio is 11.50, with an EV/FCF ratio of -2.35.
EV to Sales0.54
EV to EBITDA11.50
EV to Free Cash Flow-2.35
EV to Operating Cash Flow-3.35
Balance Sheet
MEDIROM Healthcare Technologies has $144.65M in cash and marketable securities with $3.91B in debt, giving a net cash position of -$3.42B billion.
Cash & Marketable Securities$144.65M
Total Debt$3.91B
Net Cash-$3.42B
Net Cash Per Share-$433.31
Tangible Book Value Per Share-$66.64
Margins
Gross margin is ―, with operating margin of -0.22%, and net profit margin of 1.79%.
Gross Margin―
Operating Margin-0.22%
Pretax Margin0.57%
Net Profit Margin1.79%
EBITDA Margin4.67%
EBIT Margin1.17%
Analyst Forecast
The average price target for MEDIROM Healthcare Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―